Log in
Propaedeutics · Cardiovascular system

Risk factors for cardiovascular diseases

Cardiovascular disease (CVD) risk factors are clinical, laboratory, and demographic parameters that predispose to the development of heart and vascular pathology. Identifying them is essential for the initial assessment of patient prognosis and determining management tactics.

Age thresholdMen over 55 years old, women over 65 years old
CholesterolRisk increases when total cholesterol is above 6.5 mmol/L
Target organsHeart, kidneys, blood vessels, and retina
Creatinine in ASCMore than 2.0 mg% indicates renal failure
4 min readFor medical studentsUpdated 09/24/2026
Material prepared by WhiteCoat Pro editorial team based on platform study guidesReviewed by medical editor: Aulov A. A., general practitioner · 09/24/2026

Base stratification criteria

For the initial assessment of cardiovascular prognosis, physicians rely on key demographic indicators, lifestyle characteristics, lipid profile, and family history.

The traditional factors predisposing to vascular events include:

  • Age and gender. Risk increases significantly in men who have reached 55 years of age and in women over 65. Postmenopausal women are considered as a separate category.
  • Lifestyle. Smoking is the key negative pattern here.
  • Dyslipidemia. Total blood cholesterol is used as the primary reference point: an increase above 6.5 mmol/L is considered alarming.
  • Burdened heredity. Family history is evaluated: early onset of cardiovascular diseases in close relatives is significant (in male family members — under 55 years old, in females — under 65 years old).

Additional risk factors

This group of parameters allows for a more detailed refinement of the patient's individual profile and the identification of hidden threats.

  • Lipid metabolism disorders. In addition to total cholesterol, fractions are evaluated: a decrease in high-density lipoprotein (HDL) levels and an increase in low-density lipoprotein (LDL) levels serve as an unfavorable background.
  • Metabolic shifts. Include diabetes mellitus, impaired glucose tolerance, and the presence of obesity.
  • Laboratory markers. Special attention is paid to indicators of inflammation and the hemostatic system. Increased fibrinogen levels, hyperhomocysteinemia, elevated C-reactive protein (CRP), as well as pathological changes in the fibrinolysis system (specifically affecting tissue plasminogen activator and its type 1 inhibitor) increase the risk.
  • Hormonal and social aspects. Estrogen deficiency, sedentary lifestyle (hypodynamia), low socioeconomic status of the patient, and ethnicity are additionally taken into account.
Test your knowledgeTasks from the "Propaedeutics" course bank — get answers and explanations instantly.

Subclinical target organ damage

Before the full clinical picture of CVD develops, asymptomatic changes occur in the organs that take the first hit. These changes are detected exclusively using instrumental or laboratory diagnostic methods.

  1. Heart. Left ventricular hypertrophy develops. It can be confirmed by ECG, echocardiography (EchoCG), or radiography.
  2. Kidneys. The appearance of proteinuria and/or a moderate increase in blood creatinine levels (ranging from 1.2 to 2.0 mg%) indicates renal tissue damage.
  3. Vascular bed. This includes generalized or focal narrowing of retinal arteries, as well as the detection of atherosclerotic plaques (in the aorta, carotid, femoral, or iliac arteries) using ultrasound or X-ray diagnostics.

Associated clinical conditions (ACC)

If target organ damage represents the preclinical stage, ACCs constitute already manifested acute events or the presence of severe chronic pathology. The presence of ACCs places the patient in the very high-risk group.

  • Cerebrovascular diseases. History may include transient ischemic attack (TIA), ischemic or hemorrhagic stroke.
  • Heart diseases. Include angina pectoris, prior myocardial infarction, congestive heart failure, and a history of coronary revascularization.
  • Severe kidney diseases. Characterized by the development of diabetic nephropathy or pronounced renal failure (when blood creatinine exceeds 2.0 mg%).
  • Severe vascular pathologies. The most formidable condition among those listed in this group is aortic dissection.

Briefly: answers to topical questions

What ECG indices and criteria are used to diagnose left ventricular hypertrophy?

Diagnosis of left ventricular hypertrophy by ECG is based on the evaluation of voltage criteria and combined indices. The main parameters used are:

  • Sokolow–Lyon index — the sum of amplitudes $S_{V1} + R_{V5-6}$ exceeds 35 mm.
  • Cornell voltage index — the sum of $R_{aVL} + S_{V3}$ is more than 28 mm for men and more than 20 mm for women.
  • Cornell product — the value $(R_{aVL} + S_{V5}) \times QRS$ exceeds 2440 mm×ms (6 mm is added to the index for women).
  • R-wave amplitude in lead aVL — is $\ge 11$ mm.

Isolated amplitude signs are additionally considered: R wave in standard and augmented leads greater than 20 mm, S wave in V₁ greater than 25 mm, and displacement of the R amplitude maximum to leads V₅ and V₆.

What are the target LDL cholesterol levels established for patients at very high cardiovascular risk?

For patients at very high cardiovascular risk, the target low-density lipoprotein level is less than 1.4 mmol/L.

How to memorize

It is easy to remember the age risk thresholds using the "55/65" rule: for men, the critical age for risk onset and hereditary assessment is 55 years, and for women, 65 years.

Class and exam questions

How to differentiate subclinical renal damage from an associated clinical condition (ACC)?

The difference lies in blood creatinine levels. In subclinical target organ damage, the elevation is moderate (1.2–2.0 mg%), whereas in associated clinical conditions (ACC), renal failure is recorded with creatinine greater than 2.0 mg% or diabetic nephropathy.

Which lipid panel parameters are classified as additional risk factors?

Additional factors include a decrease in "good" cholesterol (HDL) and an increase in "bad" cholesterol (LDL). Meanwhile, total cholesterol > 6.5 mmol/L is considered a traditional factor.

In which blood vessels are atherosclerotic plaques sought to confirm target organ damage?

The search for plaques using ultrasound or X-ray is performed in the aorta, carotid, femoral, and iliac arteries.

Something unclear? Ask the AIThe AI tutor has read the material on "Cardiovascular Disease Risk Factors" and will explain it in simple terms.

What else to study on this topic

  • Mechanisms of left ventricular hypertrophy development
  • The role of C-reactive protein and fibrinogen in the pathogenesis of vascular events
  • Differences between transient ischemic attack and ischemic stroke
  • Pathophysiology of diabetic nephropathy
  • The effect of hyperhomocysteinemia on the vascular endothelium

Master the entire topic in the "Propaedeutics" course

This is a summary. The course covers everything tested in classes and exams.

  • Complete study guide on "Cardiovascular Disease Risk Factors" and 3,152 more pages on the subject
  • Assignments and quizzes after every topic — just like in a colloquium
  • AI tutor answers questions on the topic anytime
  • 113 video lessons on the subject

Other topics in the "Cardiovascular system" section

The entire "Cardiovascular system" section

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.